News

Certification by the Swiss Biobanking Platform – VITA-Label
Building up a proper Governance through accountable mechanisms is key to foster trustworthiness and the pre-requisite for the appropriate use of biological resources. Our CK-CARE

CK-CARE Team Meeting October 10th- 11th, 2022
This year’s CK-CARE team event in Davos focused on strengthening cross-center communication and collaboration.

Certification by the Swiss Biobanking Platform – OPTIMA-Label
Davos BioSciences AG achieved the official OPTIMA label of the Swiss Biobanking Platform for its biobank infrastructure as of 30.05.2022. This is another important step

Certification by the Swiss Biobanking Platform
After some effort, Davos BioSciences AG achieved the official NORMA label of the Swiss Biobanking Platform for its biobank infrastructure as of 17.08.2021. This is

Claudio Rhyner, PhD appointed as the new Managing Director
On 1 October 2020, Claudio Rhyner succeeded Dr. Georg Schäppi as Managing Director of CK-CARE. Georg Schäppi was appointed CEO at the University Children’s Hospital

Atopic dermatitis: an expanding therapeutic pipeline for a complex disease
Our founder, Prof. Thomas Bieber, published an important contribution in the treatment of AD: Atopic dermatitis (AD) is a common chronic inflammatory skin disease with